Table 1.
Characteristic | % (n) of Patients |
---|---|
Total patients, n | 1235 |
Sex, n = 1081 | |
Male | 62.0% (670) |
Female | 38.0% (411) |
Ratio (male to female) | 1.6 |
Age, n = 800 | |
Mean | 56.1 ± 5.4 |
Range | 13-85 |
Previous sacral surgery, n = 601 | 20.5% (123) |
Symptoms at presentation | |
Pain, n = 308 | 86.7% (267) |
Mass/swelling, n = 177 | 50.3% (89) |
Bowel dysfunction, n = 171 | 27.5% (47) |
Bladder dysfunction, n = 180 | 18.9% (34) |
Neuropathic pain, n = 124 | 16.1% (20) |
Neurologic symptoms: unspecified or other, n ==190 | 21.1% (40) |
Follow-up, n = 956 | |
Mean (months) | 72.0 ± 27.5 |
Range (years) | 0-34 |
Abbreviation: n, number of patients at risk (in studies reporting characteristic).
aA total of 1235 surgical sacral chordoma patients were included. Among the patients for whom gender was known, 62% were male, giving a male-to-female ratio of 1.6:1. The mean age at diagnosis of sacral chordoma was 56.1 ± 5.4 (range 13-85).